Ikeda, H. O., Muraoka, Y., Hata, M., Sumi, E., Ikeda, T., Nakagawa, T., . . . Tsujikawa, A. (2020). Safety and effectiveness of a novel neuroprotectant, KUS121, in patients with non-arteritic central retinal artery occlusion: An open-label, non-randomized, first-in-humans, phase 1/2 trial. PLoS One.
Παραπομπή Chicago StyleIkeda, Hanako Ohashi, et al. "Safety and Effectiveness of a Novel Neuroprotectant, KUS121, in Patients With Non-arteritic Central Retinal Artery Occlusion: An Open-label, Non-randomized, First-in-humans, Phase 1/2 Trial." PLoS One 2020.
Παραπομπή MLAIkeda, Hanako Ohashi, et al. "Safety and Effectiveness of a Novel Neuroprotectant, KUS121, in Patients With Non-arteritic Central Retinal Artery Occlusion: An Open-label, Non-randomized, First-in-humans, Phase 1/2 Trial." PLoS One 2020.